Clinical Trials

The FDA placed a clinical hold on a phase 1 study designed to evaluate UCARTCS1A for the treatment of patients with relapsed or refractory multiple myeloma, according to a press release from the agent’s manufacturer.

As the director of The University of Arizona Cancer Center's Clinical Trials Office, and national expert in pancreatic and biliary cancers, Rachna Shroff, MD, shares the impact COVID-19 has had on our patients, clinical trials, and cancer care.

Enrollment of children in cancer clinical trials historically has been much more robust than that of adults and has driven significant improvements in the treatment of pediatric cancers.

Black patients with cancer have been significantly underrepresented in pharmaceutical company-sponsored clinical trials, according to study results presented at American Association for Cancer Research Virtual Annual Meeting II.

African Americans have been routinely underrepresented in clinical trials supporting FDA approval of drugs for all types of cancer, according to results of a retrospective study published in Annals of Internal Medicine.

African American and Hispanic populations were often underrepresented in clinical trials of treatments for atrial fibrillation, according to a research letter published in JACC: Clinical Electrophysiology.

The American College of Cardiology announced the launch of a program to promote the involvement of women and underrepresented groups in careers in clinical trial research.

Data from clinical trials show that findings often do not apply to minority populations, and trialists must adopt cultural competency practices to recruit and retain black participants, according to a speaker.

Patients with cancer who either had Medicaid or no health insurance derived smaller benefits from experimental therapies than standard therapies in clinical trials, according to results of a meta-analysis published in JAMA Network Open.

Vinay Prasad, MD, MPH, an academic oncologist and host of the podcast Plenary Session, shares insight on his recently published book Malignant, his thoughts on the unsustainability of the current state of oncology, and provides guidance on how to navigate modern day oncology and the complexities of constantly evolving cancer care.